What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
.
. Nature. 2021 Sep;597(7877):561-565. doi: 10.1038/s41586-021-03887-4. Epub 2021 Sep 8. Nature. 2021. PMID: 34497418
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
